

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, classical pathway (GO:0006958) | 9.32752115 |
| 2 | complement activation (GO:0006956) | 7.34167974 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.26786234 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.15926114 |
| 5 | positive regulation of respiratory burst (GO:0060267) | 7.01061627 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.81513740 |
| 7 | glomerular filtration (GO:0003094) | 5.88288981 |
| 8 | protein activation cascade (GO:0072376) | 5.33913685 |
| 9 | renal filtration (GO:0097205) | 5.25909098 |
| 10 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 5.21643402 |
| 11 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 5.21643402 |
| 12 | Fc-gamma receptor signaling pathway (GO:0038094) | 5.21643402 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.20911280 |
| 14 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 5.17563367 |
| 15 | regulation of respiratory burst (GO:0060263) | 4.84255653 |
| 16 | detection of bacterium (GO:0016045) | 4.82694127 |
| 17 | humoral immune response (GO:0006959) | 4.72149821 |
| 18 | detection of other organism (GO:0098543) | 4.62769148 |
| 19 | cellular response to type I interferon (GO:0071357) | 4.55569035 |
| 20 | type I interferon signaling pathway (GO:0060337) | 4.55569035 |
| 21 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.55291871 |
| 22 | response to type I interferon (GO:0034340) | 4.50082070 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 4.44827504 |
| 24 | antimicrobial humoral response (GO:0019730) | 4.39998727 |
| 25 | antibacterial humoral response (GO:0019731) | 4.37128471 |
| 26 | negative regulation of cell killing (GO:0031342) | 4.31837672 |
| 27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.31837672 |
| 28 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.07893505 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.07893505 |
| 30 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.07893505 |
| 31 | modulation by symbiont of host immune response (GO:0052553) | 4.07893505 |
| 32 | positive regulation by symbiont of host defense response (GO:0052509) | 4.07893505 |
| 33 | modulation by symbiont of host defense response (GO:0052031) | 4.07893505 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.92377645 |
| 35 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.88295228 |
| 36 | B cell receptor signaling pathway (GO:0050853) | 3.83385309 |
| 37 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.78011026 |
| 38 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.67131331 |
| 39 | cellular response to interferon-gamma (GO:0071346) | 3.62382166 |
| 40 | retina homeostasis (GO:0001895) | 3.59714349 |
| 41 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.59077002 |
| 42 | B cell mediated immunity (GO:0019724) | 3.57903917 |
| 43 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.53407214 |
| 44 | regulation of cellular extravasation (GO:0002691) | 3.52926518 |
| 45 | regulation of antigen processing and presentation (GO:0002577) | 3.42902679 |
| 46 | detection of external biotic stimulus (GO:0098581) | 3.39690461 |
| 47 | response to interferon-gamma (GO:0034341) | 3.34600018 |
| 48 | germinal center formation (GO:0002467) | 3.31710890 |
| 49 | myeloid dendritic cell differentiation (GO:0043011) | 3.18949455 |
| 50 | response to host immune response (GO:0052572) | 3.16346414 |
| 51 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.16346414 |
| 52 | B cell homeostasis (GO:0001782) | 3.13265371 |
| 53 | positive regulation of antigen processing and presentation (GO:0002579) | 3.09918747 |
| 54 | surfactant homeostasis (GO:0043129) | 3.06868668 |
| 55 | myeloid dendritic cell activation (GO:0001773) | 3.05667541 |
| 56 | production of molecular mediator of immune response (GO:0002440) | 3.04448629 |
| 57 | positive regulation of B cell differentiation (GO:0045579) | 3.03369253 |
| 58 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.00123508 |
| 59 | T cell costimulation (GO:0031295) | 2.98886889 |
| 60 | NIK/NF-kappaB signaling (GO:0038061) | 2.97833786 |
| 61 | macrophage activation involved in immune response (GO:0002281) | 2.96150607 |
| 62 | immune response-activating signal transduction (GO:0002757) | 2.95325510 |
| 63 | lymphocyte costimulation (GO:0031294) | 2.94303699 |
| 64 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.91766981 |
| 65 | response to host (GO:0075136) | 2.91766981 |
| 66 | response to host defenses (GO:0052200) | 2.91766981 |
| 67 | T-helper 1 type immune response (GO:0042088) | 2.86319354 |
| 68 | T cell migration (GO:0072678) | 2.84599434 |
| 69 | detection of biotic stimulus (GO:0009595) | 2.84232489 |
| 70 | positive regulation of interferon-alpha production (GO:0032727) | 2.81467222 |
| 71 | activation of immune response (GO:0002253) | 2.80202526 |
| 72 | regulation of gamma-delta T cell activation (GO:0046643) | 2.79125666 |
| 73 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.79105742 |
| 74 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.78798852 |
| 75 | positive thymic T cell selection (GO:0045059) | 2.73418446 |
| 76 | COPI coating of Golgi vesicle (GO:0048205) | 2.71778538 |
| 77 | Golgi transport vesicle coating (GO:0048200) | 2.71778538 |
| 78 | regulation of integrin activation (GO:0033623) | 2.71609542 |
| 79 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.70704383 |
| 80 | response to interferon-beta (GO:0035456) | 2.70434545 |
| 81 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.67654535 |
| 82 | negative regulation of bone resorption (GO:0045779) | 2.67459159 |
| 83 | angiotensin maturation (GO:0002003) | 2.66507879 |
| 84 | negative regulation of myotube differentiation (GO:0010832) | 2.60980747 |
| 85 | regulation of interferon-alpha production (GO:0032647) | 2.57287633 |
| 86 | negative thymic T cell selection (GO:0045060) | 2.56891041 |
| 87 | response to interferon-alpha (GO:0035455) | 2.54157230 |
| 88 | B cell proliferation (GO:0042100) | 2.51842540 |
| 89 | regulation of T cell tolerance induction (GO:0002664) | 2.51588886 |
| 90 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.49063754 |
| 91 | positive regulation of Rap GTPase activity (GO:0032854) | 2.48362224 |
| 92 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.47815728 |
| 93 | chronic inflammatory response (GO:0002544) | 2.47470317 |
| 94 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.47317224 |
| 95 | response to interleukin-15 (GO:0070672) | 2.46597178 |
| 96 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.45702184 |
| 97 | respiratory burst (GO:0045730) | 2.45504675 |
| 98 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.43030560 |
| 99 | peptide catabolic process (GO:0043171) | 2.42461436 |
| 100 | negative regulation of innate immune response (GO:0045824) | 2.41727562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.97738036 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.37186842 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.85159550 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.73166936 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.41683042 |
| 6 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.37166002 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.33606639 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.10785707 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.74361508 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.72250802 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64410573 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.45597704 |
| 13 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.43598055 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.40902157 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.40322598 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.38592392 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.25401184 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.18063534 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.14171226 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.13257684 |
| 21 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.10663308 |
| 22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.07496845 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.07393367 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.05229915 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.05042518 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 1.93255552 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.90514151 |
| 28 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.87106528 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.80814867 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.80665663 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.74134182 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.71753829 |
| 33 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.68161887 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 1.65582191 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.65275510 |
| 36 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.62919988 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.60676232 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.56444343 |
| 39 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.55943944 |
| 40 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.52427910 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.49759997 |
| 42 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49386822 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41157326 |
| 44 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.40421985 |
| 45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.39997296 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38529022 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.37191369 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32288711 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.27105588 |
| 50 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.26659448 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26213420 |
| 52 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.26121891 |
| 53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22591444 |
| 54 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.22279960 |
| 55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20365378 |
| 56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20100725 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17538119 |
| 58 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17491600 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17164041 |
| 60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.15052341 |
| 61 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15004157 |
| 62 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14077752 |
| 63 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10855962 |
| 64 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10566662 |
| 65 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.10290407 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09965404 |
| 67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06815204 |
| 68 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04939505 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00349439 |
| 70 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98870248 |
| 71 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98790165 |
| 72 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97836171 |
| 73 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97008798 |
| 74 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95941612 |
| 75 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95484656 |
| 76 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.95304105 |
| 77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94933490 |
| 78 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94138073 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93641457 |
| 80 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93224557 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91533881 |
| 82 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91495258 |
| 83 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91405873 |
| 84 | MAF_26560356_Chip-Seq_TH2_Human | 0.90249240 |
| 85 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.90106857 |
| 86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90020592 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87442092 |
| 88 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87439608 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87225682 |
| 90 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.86967880 |
| 91 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86522042 |
| 92 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.86406720 |
| 93 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.83790776 |
| 94 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83625388 |
| 95 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.81386225 |
| 96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79696521 |
| 97 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79588152 |
| 98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.79540494 |
| 99 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.76808325 |
| 100 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.76317192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.18743928 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.95224512 |
| 3 | MP0003724_increased_susceptibility_to | 3.78330857 |
| 4 | MP0001790_abnormal_immune_system | 3.31152646 |
| 5 | MP0005387_immune_system_phenotype | 3.31152646 |
| 6 | MP0000685_abnormal_immune_system | 3.28178588 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 3.21364695 |
| 8 | MP0001800_abnormal_humoral_immune | 3.09660862 |
| 9 | MP0003436_decreased_susceptibility_to | 2.90703951 |
| 10 | MP0005671_abnormal_response_to | 2.84497406 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.82232963 |
| 12 | MP0010155_abnormal_intestine_physiology | 2.69386491 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.61538084 |
| 14 | MP0005025_abnormal_response_to | 2.56705341 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.49980666 |
| 16 | MP0009785_altered_susceptibility_to | 2.43709292 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.39812201 |
| 18 | MP0002723_abnormal_immune_serum | 2.24535401 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.23660437 |
| 20 | MP0001819_abnormal_immune_cell | 2.15275876 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.14689154 |
| 22 | MP0004264_abnormal_extraembryonic_tissu | 2.11767279 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.04611077 |
| 24 | MP0002419_abnormal_innate_immunity | 2.00578587 |
| 25 | MP0010352_gastrointestinal_tract_polyps | 1.96780467 |
| 26 | MP0003866_abnormal_defecation | 1.93113414 |
| 27 | MP0003763_abnormal_thymus_physiology | 1.91466351 |
| 28 | MP0002006_tumorigenesis | 1.91397331 |
| 29 | MP0000465_gastrointestinal_hemorrhage | 1.83247179 |
| 30 | MP0005275_abnormal_skin_tensile | 1.80779851 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.76324401 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.74267921 |
| 33 | MP0004947_skin_inflammation | 1.69500514 |
| 34 | MP0005166_decreased_susceptibility_to | 1.66702696 |
| 35 | MP0002139_abnormal_hepatobiliary_system | 1.65664839 |
| 36 | MP0000716_abnormal_immune_system | 1.62482217 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.61684034 |
| 38 | MP0004782_abnormal_surfactant_physiolog | 1.58385014 |
| 39 | MP0002398_abnormal_bone_marrow | 1.58220967 |
| 40 | MP0005310_abnormal_salivary_gland | 1.58053456 |
| 41 | MP0001873_stomach_inflammation | 1.52963878 |
| 42 | MP0002796_impaired_skin_barrier | 1.46076646 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.43091512 |
| 44 | MP0006082_CNS_inflammation | 1.41351596 |
| 45 | MP0003045_fibrosis | 1.37637621 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.33743737 |
| 47 | MP0003252_abnormal_bile_duct | 1.33514682 |
| 48 | MP0002429_abnormal_blood_cell | 1.30820526 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.29175864 |
| 50 | MP0001663_abnormal_digestive_system | 1.22556059 |
| 51 | MP0000858_altered_metastatic_potential | 1.21945453 |
| 52 | MP0003868_abnormal_feces_composition | 1.21111252 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.19146390 |
| 54 | MP0002722_abnormal_immune_system | 1.14245269 |
| 55 | MP0003075_altered_response_to | 1.14243876 |
| 56 | MP0001666_abnormal_nutrient_absorption | 1.14172172 |
| 57 | MP0002405_respiratory_system_inflammati | 1.13402637 |
| 58 | MP0005451_abnormal_body_composition | 1.12546337 |
| 59 | MP0003448_altered_tumor_morphology | 1.12489651 |
| 60 | MP0008469_abnormal_protein_level | 1.10680494 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.10087805 |
| 62 | MP0000490_abnormal_crypts_of | 1.09689473 |
| 63 | MP0008004_abnormal_stomach_pH | 1.07500999 |
| 64 | MP0008438_abnormal_cutaneous_collagen | 1.07450598 |
| 65 | MP0000343_altered_response_to | 1.06978435 |
| 66 | MP0003091_abnormal_cell_migration | 1.02411292 |
| 67 | MP0002877_abnormal_melanocyte_morpholog | 1.02197800 |
| 68 | MP0000477_abnormal_intestine_morphology | 0.99201909 |
| 69 | MP0003453_abnormal_keratinocyte_physiol | 0.98036398 |
| 70 | MP0002009_preneoplasia | 0.92038601 |
| 71 | MP0009764_decreased_sensitivity_to | 0.91729405 |
| 72 | MP0009840_abnormal_foam_cell | 0.86862896 |
| 73 | MP0005381_digestive/alimentary_phenotyp | 0.86491553 |
| 74 | MP0002933_joint_inflammation | 0.86284227 |
| 75 | MP0005085_abnormal_gallbladder_physiolo | 0.83440087 |
| 76 | MP0005023_abnormal_wound_healing | 0.83301823 |
| 77 | MP0000249_abnormal_blood_vessel | 0.82797454 |
| 78 | MP0004858_abnormal_nervous_system | 0.82459795 |
| 79 | MP0000604_amyloidosis | 0.82381644 |
| 80 | MP0002396_abnormal_hematopoietic_system | 0.81756167 |
| 81 | MP0008260_abnormal_autophagy | 0.81428117 |
| 82 | MP0001851_eye_inflammation | 0.81127153 |
| 83 | MP0000703_abnormal_thymus_morphology | 0.77859117 |
| 84 | MP0003566_abnormal_cell_adhesion | 0.77493746 |
| 85 | MP0001216_abnormal_epidermal_layer | 0.77465606 |
| 86 | MP0009643_abnormal_urine_homeostasis | 0.77102292 |
| 87 | MP0005390_skeleton_phenotype | 0.74129466 |
| 88 | MP0005165_increased_susceptibility_to | 0.70899542 |
| 89 | MP0005503_abnormal_tendon_morphology | 0.69020307 |
| 90 | MP0008874_decreased_physiological_sensi | 0.69001406 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.67501587 |
| 92 | MP0009763_increased_sensitivity_to | 0.67088545 |
| 93 | MP0003795_abnormal_bone_structure | 0.64484452 |
| 94 | MP0005164_abnormal_response_to | 0.64056958 |
| 95 | MP0005220_abnormal_exocrine_pancreas | 0.63958565 |
| 96 | MP0002277_abnormal_respiratory_mucosa | 0.63429698 |
| 97 | MP0002876_abnormal_thyroid_physiology | 0.61440324 |
| 98 | MP0005360_urolithiasis | 0.60879545 |
| 99 | MP0010678_abnormal_skin_adnexa | 0.59921988 |
| 100 | MP0000609_abnormal_liver_physiology | 0.59708099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bronchitis (HP:0002837) | 5.05055919 |
| 2 | Gastrointestinal stroma tumor (HP:0100723) | 4.72719601 |
| 3 | Agammaglobulinemia (HP:0004432) | 4.69003078 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.67653814 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.67370568 |
| 6 | Prostate neoplasm (HP:0100787) | 4.64867752 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.52268764 |
| 8 | Vasculitis (HP:0002633) | 4.39378095 |
| 9 | Increased IgE level (HP:0003212) | 3.82200358 |
| 10 | Meningitis (HP:0001287) | 3.81225014 |
| 11 | Abnormality of the prostate (HP:0008775) | 3.81071330 |
| 12 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.77063578 |
| 13 | Cellulitis (HP:0100658) | 3.70626358 |
| 14 | Colitis (HP:0002583) | 3.55967138 |
| 15 | Malnutrition (HP:0004395) | 3.43513245 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.37709931 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 3.37212780 |
| 18 | Chronic otitis media (HP:0000389) | 3.35588290 |
| 19 | Spontaneous hematomas (HP:0007420) | 3.33858271 |
| 20 | Recurrent sinusitis (HP:0011108) | 3.32206384 |
| 21 | Recurrent viral infections (HP:0004429) | 3.30950176 |
| 22 | Emphysema (HP:0002097) | 3.25097295 |
| 23 | Osteomyelitis (HP:0002754) | 3.15693752 |
| 24 | Skin rash (HP:0000988) | 3.15462452 |
| 25 | Chronic diarrhea (HP:0002028) | 3.14883926 |
| 26 | Inflammation of the large intestine (HP:0002037) | 3.14761815 |
| 27 | IgA deficiency (HP:0002720) | 3.14733777 |
| 28 | IgM deficiency (HP:0002850) | 3.14508229 |
| 29 | Bronchitis (HP:0012387) | 3.10817578 |
| 30 | Abnormality of complement system (HP:0005339) | 3.10583382 |
| 31 | Urticaria (HP:0001025) | 3.08852557 |
| 32 | Recurrent abscess formation (HP:0002722) | 3.06578256 |
| 33 | Glomerulonephritis (HP:0000099) | 3.00570095 |
| 34 | Gastrointestinal inflammation (HP:0004386) | 2.99772634 |
| 35 | Gastrointestinal infarctions (HP:0005244) | 2.98338550 |
| 36 | Mediastinal lymphadenopathy (HP:0100721) | 2.90625993 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 2.76451026 |
| 38 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.76451026 |
| 39 | Premature loss of primary teeth (HP:0006323) | 2.75629874 |
| 40 | Abnormality of the nasal mucosa (HP:0000433) | 2.74612838 |
| 41 | Complement deficiency (HP:0004431) | 2.74223561 |
| 42 | Lymphopenia (HP:0001888) | 2.72872959 |
| 43 | Recurrent pneumonia (HP:0006532) | 2.71261917 |
| 44 | Autoimmune hemolytic anemia (HP:0001890) | 2.70144376 |
| 45 | Pulmonary infiltrates (HP:0002113) | 2.69231410 |
| 46 | Recurrent fungal infections (HP:0002841) | 2.68855808 |
| 47 | Abnormality of T cell physiology (HP:0011840) | 2.63795233 |
| 48 | Orchitis (HP:0100796) | 2.63319057 |
| 49 | Hemoptysis (HP:0002105) | 2.63039777 |
| 50 | Leukocytosis (HP:0001974) | 2.62975503 |
| 51 | Abnormality of B cell number (HP:0010975) | 2.62961856 |
| 52 | Recurrent skin infections (HP:0001581) | 2.62799309 |
| 53 | Hypergammaglobulinemia (HP:0010702) | 2.60902643 |
| 54 | Recurrent lower respiratory tract infections (HP:0002783) | 2.58843389 |
| 55 | Gingivitis (HP:0000230) | 2.57033657 |
| 56 | Myositis (HP:0100614) | 2.54457171 |
| 57 | Restrictive lung disease (HP:0002091) | 2.50003155 |
| 58 | Verrucae (HP:0200043) | 2.49408514 |
| 59 | Papilloma (HP:0012740) | 2.49408514 |
| 60 | Nephritis (HP:0000123) | 2.48199927 |
| 61 | Hyperactive renin-angiotensin system (HP:0000841) | 2.47819366 |
| 62 | Obstructive lung disease (HP:0006536) | 2.44145852 |
| 63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.44145852 |
| 64 | Xerostomia (HP:0000217) | 2.40104657 |
| 65 | Skin ulcer (HP:0200042) | 2.37503946 |
| 66 | Nasal polyposis (HP:0100582) | 2.36691814 |
| 67 | Optic neuritis (HP:0100653) | 2.34547460 |
| 68 | Retrobulbar optic neuritis (HP:0100654) | 2.34547460 |
| 69 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.33741390 |
| 70 | Villous atrophy (HP:0011473) | 2.33741390 |
| 71 | Increased IgM level (HP:0003496) | 2.32428767 |
| 72 | Abnormality of T cell number (HP:0011839) | 2.31058497 |
| 73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.29515682 |
| 74 | Abnormality of T cells (HP:0002843) | 2.28155183 |
| 75 | Abnormality of male internal genitalia (HP:0000022) | 2.27549847 |
| 76 | Sepsis (HP:0100806) | 2.25371631 |
| 77 | B lymphocytopenia (HP:0010976) | 2.23582810 |
| 78 | Panhypogammaglobulinemia (HP:0003139) | 2.21610706 |
| 79 | Interstitial pulmonary disease (HP:0006530) | 2.21469351 |
| 80 | Chest pain (HP:0100749) | 2.20220294 |
| 81 | Encephalitis (HP:0002383) | 2.18052133 |
| 82 | Alopecia of scalp (HP:0002293) | 2.16591012 |
| 83 | Keratoconjunctivitis sicca (HP:0001097) | 2.15820916 |
| 84 | Chronic sinusitis (HP:0011109) | 2.14896546 |
| 85 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.14574128 |
| 86 | Autoimmune thrombocytopenia (HP:0001973) | 2.04068775 |
| 87 | Hypermelanotic macule (HP:0001034) | 2.03532481 |
| 88 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.02433043 |
| 89 | Pustule (HP:0200039) | 2.00601132 |
| 90 | Abnormal tarsal ossification (HP:0008369) | 1.97943626 |
| 91 | Gangrene (HP:0100758) | 1.97562602 |
| 92 | Abnormality of nail color (HP:0100643) | 1.94904862 |
| 93 | Abnormality of the pleura (HP:0002103) | 1.94517952 |
| 94 | Abnormality of the peritoneum (HP:0002585) | 1.93452174 |
| 95 | Neoplasm of the lung (HP:0100526) | 1.93429549 |
| 96 | Lymphoma (HP:0002665) | 1.93101515 |
| 97 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.91486325 |
| 98 | T lymphocytopenia (HP:0005403) | 1.91321180 |
| 99 | Keratoconjunctivitis (HP:0001096) | 1.90644258 |
| 100 | Cheilitis (HP:0100825) | 1.90584329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.69844384 |
| 2 | RIPK4 | 4.33298070 |
| 3 | FGFR4 | 3.90421044 |
| 4 | PRPF4B | 3.72428794 |
| 5 | MAP4K1 | 3.72099938 |
| 6 | TYK2 | 3.47240551 |
| 7 | BLK | 2.67625244 |
| 8 | JAK1 | 2.55260063 |
| 9 | KIT | 2.54735894 |
| 10 | FGFR3 | 2.40064703 |
| 11 | EPHA3 | 2.37942355 |
| 12 | IKBKE | 2.21896107 |
| 13 | MAP3K14 | 2.20059802 |
| 14 | JAK3 | 2.06385528 |
| 15 | EPHB1 | 1.83043386 |
| 16 | MST1R | 1.82492186 |
| 17 | EIF2AK3 | 1.79974447 |
| 18 | MAP3K13 | 1.69919771 |
| 19 | SYK | 1.67059609 |
| 20 | TBK1 | 1.60350603 |
| 21 | NEK9 | 1.58210556 |
| 22 | IRAK4 | 1.55859898 |
| 23 | RIPK1 | 1.49957000 |
| 24 | CSF1R | 1.47761547 |
| 25 | CDC42BPA | 1.46455435 |
| 26 | STK24 | 1.41172476 |
| 27 | CSK | 1.39362617 |
| 28 | LYN | 1.29745973 |
| 29 | JAK2 | 1.29441042 |
| 30 | MATK | 1.28538472 |
| 31 | BMPR2 | 1.28443899 |
| 32 | MAP3K1 | 1.09067006 |
| 33 | IRAK1 | 1.05846484 |
| 34 | ZAP70 | 1.03898547 |
| 35 | BTK | 1.03757240 |
| 36 | MAP3K10 | 1.02406967 |
| 37 | DDR2 | 1.01234864 |
| 38 | CDK19 | 0.95937449 |
| 39 | TRIB3 | 0.91853564 |
| 40 | SMG1 | 0.91583361 |
| 41 | PIK3CA | 0.89854240 |
| 42 | GRK6 | 0.89818579 |
| 43 | MAPK11 | 0.88639792 |
| 44 | FES | 0.87684883 |
| 45 | ACVR1B | 0.84759441 |
| 46 | KSR2 | 0.83901238 |
| 47 | LRRK2 | 0.83840864 |
| 48 | TXK | 0.82409803 |
| 49 | TGFBR1 | 0.80343503 |
| 50 | SIK3 | 0.80238529 |
| 51 | PKN2 | 0.79552676 |
| 52 | HCK | 0.77758844 |
| 53 | IKBKB | 0.77386468 |
| 54 | FGR | 0.76379811 |
| 55 | LCK | 0.74820335 |
| 56 | PDGFRA | 0.74785091 |
| 57 | NLK | 0.74012183 |
| 58 | PDK1 | 0.70514727 |
| 59 | PDPK1 | 0.69430042 |
| 60 | MAPK7 | 0.68246944 |
| 61 | TAOK3 | 0.64468501 |
| 62 | FER | 0.63741485 |
| 63 | YES1 | 0.63645861 |
| 64 | PRKG2 | 0.63408501 |
| 65 | ARAF | 0.61287714 |
| 66 | PRKCQ | 0.59524298 |
| 67 | TESK2 | 0.58432133 |
| 68 | OXSR1 | 0.57639545 |
| 69 | RET | 0.53077944 |
| 70 | ALK | 0.51207048 |
| 71 | CDK6 | 0.50846633 |
| 72 | FYN | 0.50528556 |
| 73 | MAPKAPK2 | 0.48838292 |
| 74 | IRAK3 | 0.47626998 |
| 75 | TAOK2 | 0.46876165 |
| 76 | PTK6 | 0.44577467 |
| 77 | MAPK4 | 0.42965556 |
| 78 | TEC | 0.42923876 |
| 79 | HIPK2 | 0.42349538 |
| 80 | KDR | 0.40712034 |
| 81 | PRKCD | 0.39958360 |
| 82 | EEF2K | 0.38673057 |
| 83 | ITK | 0.38400074 |
| 84 | MAP3K9 | 0.38362012 |
| 85 | MAP3K3 | 0.37975156 |
| 86 | MELK | 0.35076138 |
| 87 | TAOK1 | 0.34010437 |
| 88 | MAP3K8 | 0.29332655 |
| 89 | EPHA2 | 0.29139007 |
| 90 | MAP3K5 | 0.29127351 |
| 91 | MAPK12 | 0.28184937 |
| 92 | MAP2K3 | 0.27987123 |
| 93 | BRAF | 0.27607839 |
| 94 | MAP3K6 | 0.26988254 |
| 95 | MAP3K2 | 0.26931473 |
| 96 | TGFBR2 | 0.24974517 |
| 97 | STK10 | 0.24936076 |
| 98 | SCYL2 | 0.24525740 |
| 99 | INSR | 0.24455693 |
| 100 | ABL1 | 0.23999301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 4.03718746 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.97831783 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.84055525 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.82186283 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.64877711 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.48450986 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.09453693 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.71476201 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.54897003 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.45558521 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.41178810 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 2.39554229 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.09336873 |
| 14 | Influenza A_Homo sapiens_hsa05164 | 1.83547266 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.70611905 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.54646585 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.54114956 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.51844468 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.47663627 |
| 20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.47196032 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.45301716 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.41789097 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.35760279 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.25122511 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.22281134 |
| 26 | Hepatitis C_Homo sapiens_hsa05160 | 1.18622225 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.15856162 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13109876 |
| 29 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.11018730 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09490231 |
| 31 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.06658554 |
| 32 | Phagosome_Homo sapiens_hsa04145 | 1.06314761 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02310453 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.94468828 |
| 35 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.93348693 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87082003 |
| 37 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.82045777 |
| 38 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81646939 |
| 39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80868727 |
| 40 | Malaria_Homo sapiens_hsa05144 | 0.80403023 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.80268720 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 0.79854972 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 0.79720881 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.76631005 |
| 45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76615363 |
| 46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.75933282 |
| 47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73366250 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71891304 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71240290 |
| 50 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69282220 |
| 51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67152164 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66741851 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64157588 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63343732 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62674746 |
| 56 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.62073115 |
| 57 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61949925 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60306563 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.57917514 |
| 60 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.54022893 |
| 61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53284137 |
| 62 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51753692 |
| 63 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50097659 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45739564 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44698523 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.43689680 |
| 67 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.43103183 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42940306 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42615980 |
| 70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42534461 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42052291 |
| 72 | Mineral absorption_Homo sapiens_hsa04978 | 0.41901320 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 0.41405680 |
| 74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.41401294 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.41059815 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.40898920 |
| 77 | Legionellosis_Homo sapiens_hsa05134 | 0.37011868 |
| 78 | Salmonella infection_Homo sapiens_hsa05132 | 0.36164921 |
| 79 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35925174 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35425745 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34939082 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33970552 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.31399379 |
| 84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.31136050 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29617225 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29248641 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28772641 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.28679739 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.27772347 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27546096 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.24439786 |
| 92 | Bladder cancer_Homo sapiens_hsa05219 | 0.23999296 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.23297116 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.22476847 |
| 95 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.22092837 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21479340 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.21217494 |
| 98 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.20494178 |
| 99 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.18813682 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.18747919 |

